Needham reiterated coverage on Phathom Pharmaceuticals with a new price target

1/5/24 8:05:02 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Needham reiterated coverage of Phathom Pharmaceuticals with a rating of Buy and set a new price target of $26.00 from $23.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PHAT

Date	Price Target	Rating	Analyst
2/14/2025	$23.00	Overweight	Cantor Fitzgerald
5/3/2024	$24.00	Buy	Stifel
1/5/2024	$23.00 → $26.00	Buy	Needham
8/9/2023	$28.00	Buy	H.C. Wainwright
5/11/2023		In-line → Outperform	Evercore ISI
3/13/2023	$21.00	Buy	Craig Hallum
10/21/2022	$16.00	Buy	Jefferies
5/6/2022		Outperform → In-line	Evercore ISI